Bio-Rad Laboratories Inc. (BIO) Tops Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $298.29 +6.51%
Revenue Growth %: -4.3%
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -4.3%
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q2 EPS of $1.09, $0.14 better than the analyst estimate of $0.95. Revenue for the quarter came in at $536.8 million versus the consensus estimate of $537.58 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Why Goldman is cautious on outperforming Intel stock
- BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
